MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202637024094 A) filed by Tseti, Ioulia on February 28, 2026, for Sealed Single-Dose Container Of Levothyroxine Aqueous Solution Suitable For Oral Administration.
Inventor includes Tseti, Ioulia.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The present invention relates to blow-fill-seal (BFS) sealed single-dose containers comprising a pharmaceutical composition of an aqueous solution for use in oral administration, which composition comprises levothyroxine or liothyronine or a pharmaceutically acceptable salt thereof, preferably levothyroxine sodium, water and one or more co-solvents and is alcohol-free, exhibits a pH from 8,1 to 8,7, an average density from 1,18 to 1,23 grams per milliliter (g/ml), and viscosity from 20 to 60 cps.
Disclaimer: Curated by HT Syndication.
